{"id":"https://openalex.org/W2010450282","doi":"https://doi.org/10.1038/mt.2013.178","title":"A Novel C5a-neutralizing Mirror-image (l-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis","display_name":"A Novel C5a-neutralizing Mirror-image (l-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis","publication_year":2013,"publication_date":"2013-07-26","ids":{"openalex":"https://openalex.org/W2010450282","doi":"https://doi.org/10.1038/mt.2013.178","mag":"2010450282","pmid":"https://pubmed.ncbi.nlm.nih.gov/23887360","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3863792"},"language":"en","primary_location":{"id":"doi:10.1038/mt.2013.178","doi":"https://doi.org/10.1038/mt.2013.178","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2013.178","pdf_url":"http://www.cell.com/article/S1525001616309492/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001616309492/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024566126","display_name":"Kai Hoehlig","orcid":"https://orcid.org/0000-0002-4638-4826","observed_orcids":["https://orcid.org/0000-0002-4638-4826"]},"institutions":[{"id":"https://openalex.org/I4210148657","display_name":"Noxxon Pharma (Germany)","ror":"https://ror.org/04g007714","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210148657"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Kai Hoehlig","raw_affiliation_strings":["NOXXON Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOXXON Pharma AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210148657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024716031","display_name":"Christian Maasch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148657","display_name":"Noxxon Pharma (Germany)","ror":"https://ror.org/04g007714","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210148657"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Maasch","raw_affiliation_strings":["NOXXON Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOXXON Pharma AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210148657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042237095","display_name":"Nelli Shushakova","orcid":"https://orcid.org/0000-0003-3772-4136","observed_orcids":["https://orcid.org/0000-0003-3772-4136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nelli Shushakova","raw_affiliation_strings":["Phenos GmbH, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenos GmbH, Hannover, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109720799","display_name":"Klaus Buchner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148657","display_name":"Noxxon Pharma (Germany)","ror":"https://ror.org/04g007714","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210148657"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus Buchner","raw_affiliation_strings":["NOXXON Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOXXON Pharma AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210148657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024003678","display_name":"Markus Stefan Huber-Lang","orcid":"https://orcid.org/0000-0003-2359-6516","observed_orcids":["https://orcid.org/0000-0003-2359-6516"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Huber-Lang","raw_affiliation_strings":["Department of Traumatology, Hand, Plastic, and Reconstructive Surgery, Center of Surgery, University of Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Traumatology, Hand, Plastic, and Reconstructive Surgery, Center of Surgery, University of Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061247084","display_name":"Werner G. Purschke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148657","display_name":"Noxxon Pharma (Germany)","ror":"https://ror.org/04g007714","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210148657"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Werner G Purschke","raw_affiliation_strings":["NOXXON Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOXXON Pharma AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210148657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011976652","display_name":"Axel Vater","orcid":"https://orcid.org/0000-0003-4166-982X","observed_orcids":["https://orcid.org/0000-0003-4166-982X"]},"institutions":[{"id":"https://openalex.org/I4210148657","display_name":"Noxxon Pharma (Germany)","ror":"https://ror.org/04g007714","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210148657"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Axel Vater","raw_affiliation_strings":["NOXXON Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOXXON Pharma AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210148657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5115588097","display_name":"Sven Klu\u00dfmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148657","display_name":"Noxxon Pharma (Germany)","ror":"https://ror.org/04g007714","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210148657"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sven Klussmann","raw_affiliation_strings":["NOXXON Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOXXON Pharma AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210148657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5024566126"],"corresponding_institution_ids":["https://openalex.org/I4210148657"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":4.0233,"has_fulltext":true,"cited_by_count":95,"citation_normalized_percentile":{"value":0.9434186,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"21","issue":"12","first_page":"2236","last_page":"2246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.4219000041484833,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.4219000041484833,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.32499998807907104,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.05469999834895134,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c5a","display_name":"C5a","score":0.7960000038146973},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.8629999756813049},{"id":"https://openalex.org/keywords/spiegelmers","display_name":"Spiegelmers","score":0.781000018119812},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/polymicrobial-sepsis","display_name":"polymicrobial sepsis","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cecal-ligation-and-puncture","display_name":"cecal ligation and puncture","score":0.9900000095367432},{"id":"https://openalex.org/keywords/organ-failure","display_name":"organ failure","score":0.7620000243186951},{"id":"https://openalex.org/keywords/polymorphonuclear-leukocytes","display_name":"polymorphonuclear leukocytes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/c5a-receptor","display_name":"C5a receptor","score":0.8109999895095825},{"id":"https://openalex.org/keywords/membrane-attack-complex","display_name":"membrane attack complex","score":0.9350000023841858},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.6395817399024963},{"id":"https://openalex.org/C128972844","wikidata":"https://www.wikidata.org/wiki/Q418722","display_name":"Aptamer","level":2,"score":0.48227909207344055},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.34535276889801025},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3428744673728943},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31304189562797546},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.15192747116088867}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009102","descriptor_name":"Multiple Organ Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009102","descriptor_name":"Multiple Organ Failure","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010538","descriptor_name":"Peritonitis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D010538","descriptor_name":"Peritonitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010538","descriptor_name":"Peritonitis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015936","descriptor_name":"Complement C5a","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015936","descriptor_name":"Complement C5a","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015936","descriptor_name":"Complement C5a","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/mt.2013.178","doi":"https://doi.org/10.1038/mt.2013.178","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2013.178","pdf_url":"http://www.cell.com/article/S1525001616309492/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2852428","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3863792","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3863792","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3863792","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther","raw_type":"Text"},{"id":"pmid:23887360","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23887360","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/mt.2013.178","doi":"https://doi.org/10.1038/mt.2013.178","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2013.178","pdf_url":"http://www.cell.com/article/S1525001616309492/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2010450282.pdf","grobid_xml":"https://content.openalex.org/works/W2010450282.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1581494614","https://openalex.org/W1590582894","https://openalex.org/W1592616574","https://openalex.org/W1848411519","https://openalex.org/W1852412583","https://openalex.org/W1873906687","https://openalex.org/W1890847758","https://openalex.org/W1964164090","https://openalex.org/W1974845135","https://openalex.org/W1977509327","https://openalex.org/W1978496711","https://openalex.org/W1995921067","https://openalex.org/W2000748318","https://openalex.org/W2002950848","https://openalex.org/W2003564723","https://openalex.org/W2010222767","https://openalex.org/W2012695097","https://openalex.org/W2023945291","https://openalex.org/W2024875771","https://openalex.org/W2041887649","https://openalex.org/W2043825921","https://openalex.org/W2059633563","https://openalex.org/W2062282390","https://openalex.org/W2065033987","https://openalex.org/W2066074720","https://openalex.org/W2067892766","https://openalex.org/W2068249583","https://openalex.org/W2073812105","https://openalex.org/W2079819154","https://openalex.org/W2084265421","https://openalex.org/W2089074620","https://openalex.org/W2089718732","https://openalex.org/W2090538273","https://openalex.org/W2098572294","https://openalex.org/W2103516595","https://openalex.org/W2105751301","https://openalex.org/W2106607972","https://openalex.org/W2110385952","https://openalex.org/W2113776905","https://openalex.org/W2117271805","https://openalex.org/W2122992861","https://openalex.org/W2126878361","https://openalex.org/W2132616983","https://openalex.org/W2136648677","https://openalex.org/W2139367421","https://openalex.org/W2149103649","https://openalex.org/W2154241726","https://openalex.org/W2170285826","https://openalex.org/W2171306122","https://openalex.org/W2410716613","https://openalex.org/W3036294205"],"related_works":["https://openalex.org/W2558371469","https://openalex.org/W4254946566","https://openalex.org/W2041200121","https://openalex.org/W2139367421","https://openalex.org/W1592616574","https://openalex.org/W2278690369","https://openalex.org/W3007754594","https://openalex.org/W2039069018","https://openalex.org/W2099193072","https://openalex.org/W4235898601"],"abstract_inverted_index":{"Complement":[0],"factor":[1],"C5a":[2,38,71,106],"is":[3,97],"a":[4,24,49,93,151],"potent":[5],"proinflammatory":[6],"mediator":[7],"that":[8,32],"contributes":[9],"to":[10,34,69,109,111],"the":[11,20,56,70,80,83,117,136,139,156],"pathogenesis":[12],"of":[13,22,48,58,67,73,82,105,119,138,158],"numerous":[14],"inflammatory":[15],"diseases.":[16],"Here,":[17],"we":[18],"describe":[19],"discovery":[21],"NOX-D20,":[23],"PEGylated":[25],"biostable":[26],"mirror-image":[27],"mixed":[28],"(l-)RNA/DNA":[29],"aptamer":[30],"(Spiegelmer)":[31],"binds":[33],"mouse":[35],"and":[36,53,102,114,126,132,143],"human":[37,60,74],"with":[39,79],"picomolar":[40],"affinity.":[41],"In":[42,89,116],"vitro,":[43],"NOX-D20":[44,68,129,149],"inhibited":[45],"C5a-induced":[46],"chemotaxis":[47],"CD88-expressing":[50],"cell":[51],"line":[52],"efficiently":[54],"antagonized":[55],"activation":[57,101],"primary":[59],"polymorphonuclear":[61],"leukocytes":[62],"(PMN)":[63],"by":[64,123],"C5a.":[65],"Binding":[66],"moiety":[72],"C5":[75],"did":[76],"not":[77],"interfere":[78],"formation":[81],"terminal":[84],"membrane":[85],"attack":[86],"complex":[87],"(MAC).":[88],"sepsis,":[90],"for":[91,155],"which":[92],"specific":[94],"interventional":[95],"therapy":[96],"currently":[98],"lacking,":[99],"complement":[100],"elevated":[103],"levels":[104],"are":[107],"suggested":[108],"contribute":[110],"multiorgan":[112],"failure":[113],"mortality.":[115],"model":[118],"polymicrobial":[120],"sepsis":[121],"induced":[122],"cecal":[124],"ligation":[125],"puncture":[127],"(CLP),":[128],"attenuated":[130],"inflammation":[131],"organ":[133],"damage,":[134],"prevented":[135],"breakdown":[137],"vascular":[140],"endothelial":[141],"barrier,":[142],"improved":[144],"survival.":[145],"Our":[146],"study":[147],"suggests":[148],"as":[150],"new":[152],"therapeutic":[153],"candidate":[154],"treatment":[157],"sepsis.":[159]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}